Please use this identifier to cite or link to this item:
|Title:||Imaging genetics for utility of risks over gains and losses|
Decision making under risk
|Source:||Zhong, S., Chark, R., Ebstein, R.P., Chew, S.H. (2012). Imaging genetics for utility of risks over gains and losses. NeuroImage 59 (1) : 540-546. ScholarBank@NUS Repository. https://doi.org/10.1016/j.neuroimage.2011.07.031|
|Abstract:||One tenet of behavioral economics is the asymmetry in how decision makers evaluate risks involving gains versus risks involving losses. Correspondingly, an increasingly important question is what neuroanatomical and neurochemical correlates underpin valuation over gains and losses. By employing an imaging genetics strategy, this paper aims at identifying the specific neurotransmitter pathways underlying these decision making processes. We find enhanced striatal activation responding to increases in the magnitude of utility for risks over gains and to increases in the magnitude of disutility for risks over losses, while increased amygdala activation correlates only with the disutility for risks over losses. Stratifying brain activation by genotype, we find that a well-characterized polymorphism in the dopamine transporter (DAT1) contributes to individual differences in striatal response for gain-oriented risks, whereas a polymorphism in the serotonin transporter (STin2) partially accounts for individual differences in amygdala responses for loss-oriented risks. Together, our results suggest the role of the amygdala and corresponding serotonergic pathway in evaluating losses. This further corroborates the hypothesis of serotonin being linked to dopamine in an "opponent partnership". © 2011 Elsevier Inc.|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Dec 7, 2017
WEB OF SCIENCETM
checked on Nov 23, 2017
checked on Dec 11, 2017
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.